Spatial Genomics and Transcriptomics Market to Grow with a CAGR of 12.68% through 2030

The advancements in sequencing technology are expected to drive the growth of Global Spatial Genomics and Transcriptomics during the forecast period, 2026-2030.

According to TechSci Research report, “Spatial Genomics and Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, Global Spatial Genomics and Transcriptomics Market stood at USD 984.25 million in 2024 and is anticipated to grow with a CAGR of 12.68% in the forecast period through 2030. This can be ascribed to the increasing demand for personalized medicine, rising investment in research and development, and the growing prevalence of chronic diseases. Additionally, growing applications of spatial genomics and transcriptomics include cancer diagnosis, drug discovery, developmental biology, and neurology. Also, the increasing adoption of advanced technologies and the presence of key market players will further boost the growth of the Global Spatial Genomics And Transcriptomics Market in the forecast period.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Spatial Genomics and Transcriptomics Market”

Spatial Genomics and Transcriptomics Market can be segmented by technique, product type, application, end user, regional distribution and company.

Based on Product Type, the software segment is expected to show fastest growth over the forecast period. The increasing number of genomic research studies is driving the demand for robust software solutions to manage and interpret vast amounts of data. According to the World Health Organization, the U.S. recorded approximately 1.9 million new cancer cases in 2021, with breast, lung, colon, rectum, and prostate cancers being the most common. The rising number of cancer diagnoses is likely to increase the demand for consumables, which will further support segment growth. Additionally, collaborations, product launches, and acquisitions are expected to contribute to the research segment's expansion. For example, in October 2022, Oxford Nanopore Technologies and 10x Genomics partnered to develop consumables for single-cell and spatial full-length isoform transcript sequencing, which is expected to drive growth in the segment.

Based on Region, Asia Pacific is experiencing rapid growth in the spatial genomics and transcriptomics market. This region is expected to see significant expansion due to several factors contributing to the adoption and development of these advanced technologies. The increasing focus on drug discovery and development is one of the key drivers, as spatial genomics and transcriptomics techniques allow for more precise identification of therapeutic targets and biomarkers, which is crucial for developing effective treatments. Additionally, the region is seeing a surge in research and development investments from both public and private sectors, further accelerating the adoption of these technologies. Governments in various countries are also promoting innovation and advancing spatial omics technologies, which are becoming more integral in research and medical applications.

Major companies operating in the global Spatial Genomics and Transcriptomics market are:

• 10X Genomics Inc.
• Akoya Bioscience Ltd.
• Biospyder Technologies Inc.
• BioTechne Corporation
• Dovetail Genomics LLC
• Fluidigm Corporation
• Genomic Vision SA
• Illumina Inc.
• Lunaphore Technologies SA
• Nanostring Technolgies Inc.

Download Free Sample Report

“North America was expected to dominate the Global Spatial Genomics and Transcriptomics market due to the strong presence of major key players focusing on development of advanced genomics and proteomics along with growing focus on genomics and proteomics research for the development of novel drugs which will diagnose the chronic diseases across the region. Similarly, the increasing investments by government bodies for expanding the research across the globe and private organizations are supporting for genome research in the region Furthermore, the increasing demand for personalized medicine which will be needed for quality checking and the growing focus on precision medicine are the major factors driving the growth of the market during the forecast period. Besides, increasing development of better healthcare infrastructure and growing focuses on the modernization of treatments is further expected to create lucrative opportunities for market growth” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based global management consulting firm.

“Spatial Genomics and Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique (Spatial Transcriptomics, Spatial Genomics Analysis), By Product Type (Instruments, Consumables, Software), By Application (Translational Research, Drug discovery & development), By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of global Spatial Genomics and Transcriptomics market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the Global Spatial Genomics and Transcriptomics market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com